Efficacy and safety of using doxazosin (candura) in the treatment of patients with benign prostatic hyperplasia
- Authors: Lopatkin NA1, Alyaev Y.G1, Kogan MI1, Loran ОВ1, Маго ЕВ1, Stepanov VN1
-
Affiliations:
- Issue: No 5 (2003)
- Pages: 3-4
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/274988
- ID: 274988
Cite item
Full Text
Abstract
References
- Винаров А. 3. Медикаментозное лечение больных гиперплазией предстательной железы: Дис. ... д-ра мед. наук. - М.; 1999.
- Chappie С. Selective alpha-1-adrenoceptors antagonists in benign prostatic hyperplasia, rationale and clinical experience. Eur. Urol. 1996; 29: 129-144.
- Kirby R., Andersson K.-E., Lepor H., Steers W. D., Alpha (1)adrenoceptor selectivity and the treatment of benign prostatic hyperplasia and lower urinary tract symptoms. Prostate Cancer Prostat. Dis. 2000; 3: 76-83.
- Lepor H. Alpha blockade for the treatment of benign prostatic hyperplasia. Urol. Clin. N. Am. 1995; 22: 375-386.
- Lynch T. Exploring treatment differences among a-1-blockers. The new landscape of the BPH medical treatment. In: An official symposium of the XVIII-th Congress of the European association of urology. Madrid; 2003. 13-15.
- Hoefner K., Claes H., de Reijke Т. М. et al. Tamsulosin 0.4 mg once daily: effect on sexual function in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Eur. Urol. 1999; 36: 335-341.
- Chon J. K., Borkowski A., Partin A. W. et al. Alpha-1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia. J. Urol. (Baltimore) 1999; 161: 2002-2008.
- Christensen M., Bendix Holme J., Rasmussen P. et al. Doxazosin treatment in patients with prostatic obstruction. Scand. J. Urol. Nephrol. 1993; 27: 39-44.
- Fulton В., Wagstaff A., Sorkin E. Doxazosin. An update of it's clinical pharmacology and therapeutic applications in hypertension and benign prostatic hyperplasia. Drugs 1995; 49: 295- 320.
- Gratzke P., Kirby R. Doxazosin GITS and doxazosin standard in patients with benign prostatic hyperplasia: Double blind trial of efficacy and tolerability. Fortschr. Med. 2000; November: 83-93.
- Guthrie R. Doxazosin for benign prostatic hyperplasia in primary care. Clin. Ther. 1997; 19: 1269-1277.
- Kirby R. A randomized, double-blind crossover study of tamsulosin and controlled-release doxazosin in patients with benign prostatic hyperplasia. Br. J. Urol. Int. 2003; 91: 41-44.
- Kirby R., Andersen M., Gratzke P. et al. A combined analysis of double-blind trials of the efficacy and tolerability of doxazosingastrointestinal therapeutic system, doxazosin standard and placebo in patients with benign prostatic hyperplasia. Ibid. 2001; 87: 192-200.
Supplementary files
